Table 1.
Model input | Outcome | Estimates | Distribution | Comments | Data source |
1. Simulated population | Population | Mean consumption of calories was 332 kcal/day from full-service or fast-food restaurants (online supplemental tables 1, 8 and 9) | Gamma | Stratified by age, sex, race/ethnicity; 32 subgroups | NHANES 2013–2016 |
2. Policy effect* | |||||
a. Consumer behaviour | Policy effect | 7.3% (95% CI 4.4% to 10.1%) (online supplemental appendix 1 and appendix table 1) | Beta | One-time effect | Meta-analysis of labelling interventions on reducing calorie intake, Shangguan et al, 2019 15 |
b. Industry response | Policy effect | 5% (online supplemental appendix 1 and appendix table 2) | Beta | Assumption: no reformulation in the first year of policy intervention; restaurants will replace the high-calorie menu items with low-calorie options or reformulate the menu items in years 2 to 5 of the intervention to achieve a 5% reduction in calorie content | Calorie changes in large chain restaurants from 2008 to 201518; higher-calorie menu items eliminated in large-chain restaurants19 |
3. Effect of change in calorie intake on BMI change (kg/m2)* | Dietary effect | Among individuals with: BMI <25: 0.0015 per kcal BMI ≥25: 0.003 per kcal |
Normal | Assumption: 55 kcal per day reduction in calorie intake would lead to one pound weight loss within 1 year, with no further weight loss in the future | Hall et al, 201830; Hall et al, 201129 |
4. Etiologic effect of BMI on cancer outcomes* | Cancer outcome | RRs ranged from 1.05 to 1.50 (online supplemental table 2) | Log normal | BMI change and cancer incidence | Continuous update project (CUP) conducted by the World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) |
5. Cancer statistics* | Cancer incidence‡ and survival | online supplemental tables 3 and 4 and appendices 2 and 3, appendix tables 3 and 4 | Beta | Stratified by age, sex and race/ethnicity | NCI’s Surveillance, Epidemiology, and End Results Programme (SEER) Database; CDC’s National Programme of Cancer Registries (NPCR) Database |
6. Healthcare-related costs*† | Medical expenditures, productivity loss and patient time costs | online supplemental tables 6 and 7, appendix 6 and appendix table 7 | Gamma | Stratified by age and sex | NCI’s cancer prevalence and cost of care projections; published literature |
7. Policy costs*† | For government and industry | online supplemental appendix 5 and appendix tables 5 and 6 | Gamma | Administration and monitoring costs for government; compliance and reformulation costs for industry | FDA’s budget report; Nutrition Review Project; and FDA’s Regulatory Impact Analysis |
8. Health-related quality of life (HRQoL)* | For 13 types of cancer | Ranged from 0.64 to 0.86 (online supplemental table 5 and appendix 4) | Beta | EQ-5D§ data from published literature by cancer type | Published literature |
*Uncertainty distributions were incorporated in the probabilistic sensitivity analyses. Uncertainties in each parameter are presented in supplemental materials (online supplemental appendix table 5 and online supplemental tables 2–9).
†If the source did not provide uncertainty estimates, we assumed the standard errors were 20% of the mean estimate to generate gamma distribution.
‡Time-varying input parameter, for which the model accounted for the secular trends. Details are provided in the Supplements.
§EQ-5D is a standardised instrument developed by the EuroQol Group as a measure of health-related quality of life that can be used in a wide range of health conditions and treatments.
BMI, body mass index; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; NCI, National Cancer Institute; NHANES, National Health and Nutrition Examination Survey.